Form 4: Esperion Therapeutics CEO Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


Sheldon L. Koenig, President and CEO and a Director of Esperion Therapeutics, Inc., reported multiple transactions in common stock on July 13, 2026.

Summary

  • Disposition to the issuer: disposed of 2,121,094 Common Stock on July 13, 2026 (Direct).
  • Disposition to the issuer: disposed of 642,000 Stock Option (right to buy) on July 13, 2026 (Direct).
  • Disposition to the issuer: disposed of 753,000 Stock Option (right to buy on July 13, 2026 (Direct).
  • Disposition to the issuer: disposed of 647,460 Stock Option (right to buy) on July 13, 2026 (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Sheldon L. Koenig — Director, Officer (President and CEO)

DateTransactionSecuritySharesPriceValueHeld After
2026-07-13Disposition to the issuerCommon Stock2,121,094——0
2026-07-13Disposition to the issuerStock Option (right to buy)642,000——0
2026-07-13Disposition to the issuerStock Option (right to buy753,000——0
2026-07-13Disposition to the issuerStock Option (right to buy)647,460——0

Key Dates

DateDescription
2026-07-13Disposition to the issuer (2,121,094 shares)
2026-07-13Disposition to the issuer (642,000 shares)
2026-07-13Disposition to the issuer (753,000 shares)
2026-07-13Disposition to the issuer (647,460 shares)

Keywords

insider transaction, Form 4, ESPR, Esperion Therapeutics, Inc., neutral, Sheldon L. Koenig

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.